Ma. Grijzenhout et al., UVB IRRADIATION OF HUMAN PLATELET CONCENTRATES DOES NOT PREVENT HLA ALLOIMMUNIZATION IN RECIPIENTS, Blood, 84(10), 1994, pp. 3524-3531
Exposure of platelet concentrates (PCs) to ultraviolet B radiation (UV
B) has been advocated as an alternative method for prevention of the o
nset of HLA sensitization in recipients. In this study, pooled PCs wer
e irradiated in a Haemonetics UV irradiator (Haemonetics corp, Braintr
ee, MA) at a dose that did not induce platelet activation. The effect
of UVB irradiation on prevention of primary HLA sensitization was eval
uated in a prospective controlled clinical study performed in cardiac
patients undergoing cardiopulmonary bypass. Patients were treated with
filtered red blood cells and a single transfusion of either standard
(control group) or UVB-irradiated (UVB group) pooled platelets prepare
d from 12 donors. Five of 39 patients in the control group and 6 of 62
patients in the UVB group developed allo-antibodies against HLA antig
ens, which is not significantly different (P = .62). This unexpected f
inding prompted us to check the efficacy of UVB irradiation. We determ
ined UVB-specific DNA damage in cells by measuring the fluorescence fr
om a labeled specific monoclonal antibody against thymine dimers. With
this novel flow cytometer technique, we estimated in UVB-irradiated l
eukocytes in saline that a mean fluorescence intensity (MFI) of 47 +/-
2 arbitrary units (n = 6) correlated with abolition of alloreactivity
in mixed lymphocyte cultures and delayed cell death (within 72 hours)
. MFI in leukocytes suspended in plasma and exposed to the clinical do
se of UVB was sixfold higher (310 +/- 41 arbitrary units) and resulted
in early cell death (within 24 hours). We hypothesize that this high
level of UVB radiation induces fragmentation of the leukocytes. As a c
onsequence, the poor results of UVB irradiation may be explained by th
e onset of HLA-alloimmunization induced by soluble donor HLA class I a
ntigens processed and presented by host antigen-presenting cells. (C)
1994 by The American Society of Hematology.